Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
about
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for StrokeHost-microbiome interactions: the aryl hydrocarbon receptor and the central nervous systemDynamic regulation of serum aryl hydrocarbon receptor agonists in MSCommunicating systems in the body: how microbiota and microglia cooperate.Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Microbial metabolites in health and disease: Navigating the unknown in search of function.Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorGut dysbiosis impairs recovery after spinal cord injury.Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Tryptophan: A gut microbiota-derived metabolites regulating inflammation.The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune SystemType-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.A review of the immunomodulatory role of dietary tryptophan in livestock and poultry.Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.Environmental control of autoimmune inflammation in the central nervous system.Irritable bowel syndrome: a gut microbiota-related disorder?Microbiome-Modulated Metabolites at the Interface of Host Immunity.Immunologic impact of the intestine in metabolic disease.Interactions between the microbiota, immune and nervous systems in health and disease.Role of AHR and HIF-1α in Glioblastoma Metabolism.The Gut, Its Microbiome, and Hypertension.Type I interferon pathway in CNS homeostasis and neurological disorders.Control of immune-mediated pathology via the aryl hydrocarbon receptor.Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.The multiple pathways to autoimmunity.The remedy within: will the microbiome fulfill its therapeutic promise?The gut microbiome and liver cancer: mechanisms and clinical translation.Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple SclerosisRegulation of inflammation by microbiota interactions with the host.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health.Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.The case for autoimmune neurology.
P2860
Q28069455-2E35049E-8FAC-4F0B-B02C-26606F6976C3Q28566343-D607F046-9B22-4A2A-88F6-0D3CB3903256Q33808285-24821845-F9B9-4683-A860-2A1098315DC4Q36071876-CFFA1535-BE84-4925-80E6-B848E69B0743Q36182975-A08D9E08-E5FE-4548-BB35-B0AFBFE90B68Q36340545-D6433852-3E93-46D5-B537-7ACE28A94184Q36340571-7D9AF0C9-C4D3-4B00-9713-E9401F3CF758Q37346761-4FF08A09-9653-42C2-BE8E-D15B41E267D4Q37415195-B4D35CB6-BCF0-42FF-BDD1-1B3F2483B3FDQ37602166-61DA3902-5D66-4AA0-8576-0CC5F27791FCQ37625525-15AFD926-F24F-41EA-8F8E-D213C890612BQ37742909-48E16B65-4DA7-4286-9BB5-B993D22DD8CCQ38693735-18F04BAA-9ACB-4FA1-8097-C65DEFD0BC3AQ38699928-47038E33-ED45-4DCB-B8FB-BB94E6241AD3Q38780964-4DCC1045-62F1-4D8D-9E14-5069D5C53DA3Q38806102-09FCCA24-EAFE-445D-915E-BA73CD3A2A60Q38905774-C6FF7BA3-E2BE-4AFC-B1A4-7B6C02D9D384Q38966132-93C7B066-DB89-4D61-BE8B-1C30CDBC3B64Q38973515-8ADFBA9B-C8C7-4BE6-A36F-1F954F4E3568Q39018403-0831B500-85B1-4C63-9F52-F9DD0D9B1E98Q39030609-6CF00A47-3D8C-46DC-B161-F178CCADB08DQ39065615-4FA26AD0-0A7C-47B2-BE41-9B2B4CEC4E31Q39090621-A5312BBD-B69A-4151-B87A-F94F069ED037Q39187735-BAF8282A-C74A-40A9-8D26-E4039103FC9BQ39263759-C9C03ABE-C1D0-4695-94BA-B58FFADE2DBAQ39315038-DD021592-8B67-40D8-B66A-4CABCB1BC9AEQ39374093-F8E3D9C6-CA5F-44B4-815D-55AF8AF2349AQ39381331-DEBA7D54-92D3-452F-93B0-805D32065434Q39386100-80E710C7-2728-4A51-9972-B21532315C54Q39401642-9088D0EB-F158-4F56-A953-B7C2DEB48F19Q39414187-189DD030-8162-49EC-9F31-C2E8BBE09CCBQ39434933-78AA006A-598F-41F6-A010-6D3C24AC734BQ39443984-881CF1E6-912E-4912-8EEA-491E398DE3D1Q41205365-6AFC1448-56B6-4540-8035-461389AFC07EQ41453198-B10DF950-A947-42E8-868E-F15F77F02A4AQ41584110-6D4C22A1-5AFC-45A0-A022-CADF36EB0598Q42221329-2972E623-86F7-4A2A-8DD7-A2CF43F74ADCQ42234408-0E6E743C-5E90-4723-B81B-659AAE2DE9B7Q42263596-9D0B248A-6470-4BB7-A9D3-4CACCCC19CC8Q42331645-53E33C95-0231-4C12-A718-D3DB614B6906
P2860
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Type I interferons and microbi ...... the aryl hydrocarbon receptor.
@en
type
label
Type I interferons and microbi ...... the aryl hydrocarbon receptor.
@en
prefLabel
Type I interferons and microbi ...... the aryl hydrocarbon receptor.
@en
P2093
P2860
P50
P356
P1433
P1476
Type I interferons and microbi ...... the aryl hydrocarbon receptor.
@en
P2093
Bonny Patel
Francisco J Quintana
Guillermo Izquierdo
Hania Kébir
Ivan D Mascanfroni
Jessica E Kenison
Jorge I Alvarez
Maisa C Takenaka
Manon Blain
Marco Prinz
P2860
P2888
P304
P356
10.1038/NM.4106
P407
P50
P577
2016-05-09T00:00:00Z
P6179
1006359738